Skip to main content
. Author manuscript; available in PMC: 2013 May 15.
Published in final edited form as: J Immunol. 2012 Apr 13;188(10):4866–4875. doi: 10.4049/jimmunol.1200402

Figure 7. Signature IEL markers are expressed in other non-lymphoid tissues.

Figure 7

(A–B) C57Bl/6J mice were infected with LCMV Armstrong one day after receiving naïve Thy1.1+ P14. Three months later, lymphocytes were isolated from the indicated tissues and analyzed by flow cytometry for expression of CD103, (A) granzyme B, or (B) CD69 and CD62L. Plots gated on CD8+ Thy1.1+ lymphocytes. (C) Naïve CD45.1+ OT-I × RAG−/− CD8 T cells were transferred to RAG−/− C57Bl/6 mice. 60 days later, OT-I were isolated from the indicated tissues and analyzed for CD103, CD69, and CD62L expression. Plots gated on CD8+ CD45.1+ lymphocytes.